Improving material properties of a poloxamer P407 hydrogel-based hydroxyapatite bone substitute material by adding silica-A comparative in vivo study.
bone substitute
hydrogel
low crystalline hydroxyapatite
poloxamer 407 (P407)
rat animal model
silicon dioxide
Journal
Journal of biomedical materials research. Part B, Applied biomaterials
ISSN: 1552-4981
Titre abrégé: J Biomed Mater Res B Appl Biomater
Pays: United States
ID NLM: 101234238
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
revised:
05
03
2024
received:
26
10
2023
accepted:
02
04
2024
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
3
5
2024
Statut:
ppublish
Résumé
The structure and handling properties of a P407 hydrogel-based bone substitute material (BSM) might be affected by different poloxamer P407 and silicon dioxide (SiO
Substances chimiques
Poloxamer
106392-12-5
Hydrogels
0
Durapatite
91D9GV0Z28
Silicon Dioxide
7631-86-9
Bone Substitutes
0
Types de publication
Journal Article
Comparative Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e35405Informations de copyright
© 2024 The Authors. Journal of Biomedical Materials Research Part B: Applied Biomaterials published by Wiley Periodicals LLC.
Références
Tang CL, Mahoney JL, McKee MD, et al. Donor site morbidity following vascularized fibular grafting. Microsurgery. 1998;18(6):383‐386.
Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK, Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury. 2011;42(Suppl 2):S3‐S15.
Heimes D, Pabst A, Becker P, et al. Comparison of morbidity‐related parameters between autologous and allogeneic bone grafts for alveolar ridge augmentation from patients' perspective‐a questionnaire‐based cohort study. Clin Implant Dent Relat Res. 2023;26:170‐182.
Finkemeier CG. Bone‐grafting and bone‐graft substitutes. J Bone Joint Surg Am. 2002;84(3):454‐464.
Hettwer W. Synthetic bone replacement: current developments and perspectives. Orthopade. 2017;46(8):688‐700.
Campion CR, Chander C, Buckland T, Hing K. Increasing strut porosity in silicate‐substituted calcium‐phosphate bone graft substitutes enhances osteogenesis. J Biomed Mater Res B Appl Biomater. 2011;97(2):245‐254.
Majidinia M, Sadeghpour A, Yousefi B. The roles of signaling pathways in bone repair and regeneration. J Cell Physiol. 2018;233(4):2937‐2948.
Al‐Khateeb R, Olszewska‐Czyz I. Biological molecules in dental applications: hyaluronic acid as a companion biomaterial for diverse dental applications. Heliyon. 2020;6(4):e03722.
D'Albis G, D'Albis V, Palma M, Plantamura M, Nizar A. Use of hyaluronic acid for regeneration of maxillofacial bones. Genesis. 2022;60(8–9):e23497.
Kyyak S, Pabst A, Heimes D, Kämmerer PW. The influence of hyaluronic acid biofunctionalization of a bovine bone substitute on osteoblast activity in vitro. Materials (Basel). 2021;14(11):2885.
Kang H‐J, Park SS, Saleh T, Ahn KM, Lee BT. In vitro and in vivo evaluation of Ca/P‐hyaluronic acid/gelatin based novel dental plugs for one‐step socket preservation. Materials and Design. 2020;194:108891.
Alcantara CEP, Castro MAA, de Noronha MS, et al. Hyaluronic acid accelerates bone repair in human dental sockets: a randomized triple‐blind clinical trial. Braz Oral Res. 2018;32:e84.
Lorenz J, Barbeck M, Kirkpatrick C, Sader R, Lerner H, Ghanaati S. Injectable bone substitute material on the basis of beta‐TCP and hyaluronan achieves complete bone regeneration while undergoing nearly complete degradation. Int J Oral Maxillofac Implants. 2018;33(3):636‐644.
Bonacucina G, Spina M, Misici‐Falzi M, et al. Effect of hydroxypropyl beta‐cyclodextrin on the self‐assembling and thermogelation properties of poloxamer 407. Eur J Pharm Sci. 2007;32(2):115‐122.
Cho C‐W, Shin S‐C, Oh I‐J. Thermorheologic properties of aqueous solutions and gels of poloxamer 407. Drug Dev Ind Pharm. 1997;23(12):1227‐1232.
Veyries ML, Couarraze G, Geiger S, et al. Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm. 1999;192(2):183‐193.
Schmolka IR. Artificial skin. I. Preparation and properties of pluronic F‐127 gels for treatment of burns. J Biomed Mater Res. 1972;6(6):571‐582.
Park H, Park K. Biocompatibility issues of implantable drug delivery systems. Pharm Res. 1996;13(12):1770‐1776.
Zhou AJ, Clokie CM, Peel SA. Bone formation in algae‐derived and synthetic calcium phosphates with or without poloxamer. J Craniofac Surg. 2013;24(2):354‐359.
Li C, Yan T, Lou Z, et al. Characterization and in vitro assessment of three‐dimensional extrusion Mg‐Sr codoped SiO(2)‐complexed porous microhydroxyapatite whisker scaffolds for biomedical engineering. Biomed Eng Online. 2021;20(1):116.
Carlisle EM. Silicon as an essential trace element in animal nutrition. Ciba Found Symp. 1986;121:123‐139.
Carlisle EM. Silicon: a possible factor in bone calcification. Science. 1970;167(3916):279‐280.
Carlisle EM. Silicon: a requirement in bone formation independent of vitamin D1. Calcif Tissue Int. 1981;33(1):27‐34.
Gotz W, Tobiasch E, Witzleben S, Schulze M. Effects of silicon compounds on biomineralization, osteogenesis, and hard tissue formation. Pharmaceutics. 2019;11(3):117.
Venkatraman SK, Swamiappan S. Review on calcium‐ and magnesium‐based silicates for bone tissue engineering applications. J Biomed Mater Res A. 2020;108(7):1546‐1562.
Dau M, Ganz C, Zaage F, Frerich B, Gerber T. Hydrogel‐embedded nanocrystalline hydroxyapatite granules (elastic blocks) based on a cross‐linked polyvinylpyrrolidone as bone grafting substitute in a rat tibia model. Int J Nanomedicine. 2017;12:1‐12.
Dau M, Kämmerer PW, Henkel KO, Gerber T, Frerich B, Gundlach KKH. Bone formation in mono cortical mandibular critical size defects after augmentation with two synthetic nanostructured and one xenogenous hydroxyapatite bone substitute—in vivo animal study. Clin Oral Implants Res. 2016;27(5):597‐603.
Sarkar B, Venugopal V, Tsianou M, Alexandridis P. Adsorption of Pluronic block copolymers on silica nanoparticles. Colloids Surf A Physicochem Eng Asp. 2013;422:155‐164.
Sarkar B, Venugopal V, Bodratti AM, Tsianou M, Alexandridis P. Nanoparticle surface modification by amphiphilic polymers in aqueous media: role of polar organic solvents. J Colloid Interface Sci. 2013;397:1‐8.
Gerber T, Lenz S, Holzhüter G, et al. Nanostructured bone grafting substitutes—a pathway to Osteoinductivity. Key Engineering Materials. 2011;493–494:147‐162.
Gerike W, Bienengräber V, Henkel KO, et al. The manufacture of synthetic non‐sintered and degradable bone grafting substitutes. Folia Morphol. 2006;65(1):54‐55.
Gerber T, Holzhüter G, Götz W, Bienengräber V, Henkel KO, Rumpel E. Nanostructuring of biomaterials—a pathway to bone grafting substitute. Eur J Trauma. 2006;32:132‐140.
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother. 2010;1(2):94‐99.
Dau M, Ganz C, Zaage F, et al. In vivo comparison of a granular and putty form of a sintered and a non‐sintered silica‐enhanced hydroxyapatite bone substitute material. J Biomater Appl. 2020;34(6):864‐874.
Chang BS, Lee CK, Hong KS, et al. Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials. 2000;21(12):1291‐1298.
Habibovic P, Yuan H, van der Valk CM, Meijer G, van Blitterswijk CA, de Groot K. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials. 2005;26(17):3565‐3575.
Klein M, Goetz H, Pazen S, al‐Nawas B, Wagner W, Duschner H. Pore characteristics of bone substitute materials assessed by microcomputed tomography. Clin Oral Implants Res. 2009;20(1):67‐74.
Klein MO, Kämmerer PW, Scholz T, Moergel M, Kirchmaier CM, al‐Nawas B. Modulation of platelet activation and initial cytokine release by alloplastic bone substitute materials. Clin Oral Implants Res. 2010;21(3):336‐345.
Lee S, Li Z, Meng D, et al. Effect of silicon‐doped calcium phosphate cement on angiogenesis based on controlled macrophage polarization. Acta Biochim Biophys Sin (Shanghai). 2021;53(11):1516‐1526.
Alvarez Echazu M, Renou S, Alvarez G, Desimone M, Olmedo D. A collagen‐silica‐based biocomposite for potential application in bone tissue engineering. J Biomed Mater Res A. 2022;110(2):331‐340.
Botelho CM, Brooks RA, Best SM, et al. Human osteoblast response to silicon‐substituted hydroxyapatite. J Biomed Mater Res A. 2006;79(3):723‐730.
Zhou AJ, Peel SA, Clokie CM. An evaluation of hydroxyapatite and biphasic calcium phosphate in combination with Pluronic F127 and BMP on bone repair. J Craniofac Surg. 2007;18(6):1264‐1275.
Schliephake H, Drewes M, Mihatovic I, Schwarz F, Becker J, Iglhaut G. Use of a self‐curing resorbable polymer in vertical ridge augmentations—a pilot study in dogs. Clin Oral Implants Res. 2014;25(4):435‐440.
Miramond T, Aguado E, Goyenvalle E, Borget P, Baroth S, Daculsi G. In vivo comparative study of two injectable/moldable CalciumPhosphate bioceramics. Key Eng Mater. 2013;529:291‐295.
Huh HW, Zhao L, Kim SY. Biomineralized biomimetic organic/inorganic hybrid hydrogels based on hyaluronic acid and poloxamer. Carbohydr Polym. 2015;126:130‐140.
Beger B, Blatt S, Pabst AM, et al. Biofunctionalization of synthetic bone substitutes with angiogenic stem cells: influence on regeneration of critical‐size bone defects in an in vivo murine model. J Craniomaxillofac Surg. 2018;46(9):1601‐1608.
Cao SS, Li SY, Geng YM, et al. Prefabricated 3D‐printed tissue‐engineered bone for mandibular reconstruction: a preclinical translational study in primate. ACS Biomater Sci Eng. 2021;7(12):5727‐5738.
Nokhbatolfoghahaei H, Bastami F, Farzad‐Mohajeri S, et al. Prefabrication technique by preserving a muscular pedicle from masseter muscle as an in vivo bioreactor for reconstruction of mandibular critical‐sized bone defects in canine models. J Biomed Mater Res B Appl Biomater. 2022;110(7):1675‐1686.